HIGH-GRADE SEROUS OVARIAN CANCER PATIENT-DERIVED ORGANOIDS APPLICABLE FOR IN VIVO MODELS OF EMERGENCE OF RESISTANCE TO ANTI-VEGF TREATMENT

被引：0
|
作者：
Hladchenko, Liliia [1 ]
Kessler, Mirjana [1 ]
Trillsch, Fabian [1 ]
Burges, Alexandar [1 ]
Czogalla, Bastian [1 ]
Kraus, Fabian [1 ]
Mahner, Sven [1 ]
Chelariu-Raicu, Anca [1 ]
机构：
[1] LMU Univ Hosp, CCC Munich, Dept Obstet & Gynecol, Munich, Germany
来源：
ANTICANCER RESEARCH | 2023年 / 43卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P03
引用
收藏
页码：3377 / 3378
页数：2
相关论文
共 50 条
  • [31] Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing
    Yoshiko Nanki
    Tatsuyuki Chiyoda
    Akira Hirasawa
    Aki Ookubo
    Manabu Itoh
    Masaru Ueno
    Tomoko Akahane
    Kaori Kameyama
    Wataru Yamagami
    Fumio Kataoka
    Daisuke Aoki
    Scientific Reports, 10
  • [32] Severe Paraneoplastic Dermatomyositis in a Patient With High-Grade Serous Ovarian Cancer
    Lajoie, Catherine
    Brault, Claudele
    Fortin, Suzanne
    de Guerke, Lara
    Auclair, Marie-Helene
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2022, 44 (06) : 700 - 702
  • [33] N-Glycoproteomics of Patient-Derived Xenografts: A Strategy to Discover Tumor-Associated Proteins in High-Grade Serous Ovarian Cancer
    Sinha, Ankit
    Hussain, Ali
    Ignatchenko, Vladimir
    Ignatchenko, Alexandr
    Tang, Kwan Ho
    Ho, Victor W. H.
    Neel, Benjamin G.
    Clarke, Blaise
    Bernardini, Marcus Q.
    Ailles, Laurie
    Kislinger, Thomas
    CELL SYSTEMS, 2019, 8 (04) : 345 - +
  • [34] Activity of the MEK inhibitor Binimetinib (MEK162) in combination with paclitaxel in patient-derived xenograft models of high-grade serous ovarian carcinoma
    Winski, Shannon L.
    Bouhana, Karyn
    Rhodes, Susan
    Cable, LouAnn
    Anderson, Deborah
    Williams, Lance
    Tunquest, Brian
    Logan, Tiffany
    Vigers, Guy
    Lee, Patrice
    CANCER RESEARCH, 2015, 75
  • [35] Developing adaptive therapy to suppress the evolution of treatment resistance in high-grade serous ovarian cancer
    Hockings, Helen
    Lockley, Michelle
    Graham, Trevor
    Lakatos, Eszter
    Huang, Weini
    CANCER RESEARCH, 2022, 82 (10)
  • [36] In vivo modeling of metastatic human high-grade serous ovarian cancer in mice
    Kim, Olga
    Park, Eun Young
    Klinkebiel, David L.
    Pack, Svetlana D.
    Shin, Yong-Hyun
    Abdullaev, Zied
    Emerson, Robert E.
    Coffey, Donna M.
    Kwon, Sun Young
    Creighton, Chad J.
    Kwon, Sanghoon
    Chang, Edmund C.
    Chiang, Theodore
    Yatsenko, Alexander N.
    Chien, Jeremy
    Cheon, Dong-Joo
    Yang-Hartwich, Yang
    Nakshatri, Harikrishna
    Nephew, Kenneth P.
    Behringer, Richard R.
    Fernandez, Facundo M.
    Cho, Chi-Heum
    Vanderhyden, Barbara
    Drapkin, Ronny
    Bast, Robert C., Jr.
    Miller, Kathy D.
    Karpf, Adam R.
    Kim, Jaeyeon
    PLOS GENETICS, 2020, 16 (06):
  • [37] In vivo tumor growth of high-grade serous ovarian cancer cell lines
    Mitra, Anirban K.
    Davis, David A.
    Tomar, Sunil
    Roy, Lynn
    Gurler, Hilal
    Xie, Jia
    Lantvit, Daniel D.
    Cardenas, Horacio
    Fang, Fang
    Liu, Yueying
    Loughran, Elizabeth
    Yang, Jing
    Stack, M. Sharon
    Emerson, Robert E.
    Dahl, Karen D. Cowden
    Barbolina, Maria V.
    Nephew, Kenneth P.
    Matei, Daniela
    Burdette, Joanna E.
    GYNECOLOGIC ONCOLOGY, 2015, 138 (02) : 372 - 377
  • [38] Synergistic antitumor effects of cMet inhibitor in combination with anti-VEGF in colorectal cancer patient-derived xenograft models
    Chen, Xiangheng
    Guan, Zhonghai
    Lu, Jun
    Wang, Haohao
    Zuo, Zhongkun
    Ye, Fei
    Huang, Jiangsheng
    Teng, Lisong
    JOURNAL OF CANCER, 2018, 9 (07): : 1207 - 1217
  • [39] Functional assessment of DNA damage repair defects and the anti-tumor immune response in high grade serous ovarian cancers using patient-derived organoids
    Hill, Sarah J.
    Lizotte, Patrick
    Horowitz, Neil S.
    Muto, Michael G.
    Worley, Michael J.
    Feltmate, Colleen M.
    Kochupurakkal, Bose
    Do, Khanh T.
    Konstantinopoulos, Panagiotis
    Nucci, Marisa R.
    Liu, Joyce F.
    Matulonis, Ursula A.
    Shapiro, Geoffrey I.
    Berkowitz, Ross S.
    Crum, Christopher P.
    D'Andrea, Alan D.
    CANCER RESEARCH, 2019, 79 (13)
  • [40] Dinaciclib persistently inhibits patient-derived high-grade ovarian carcinoma growth
    Ice, R. J.
    Chen, M.
    McAllister, S.
    Salomonis, N.
    Desprez, P.
    Sidorov, M.
    Ho, T. L.
    Chan, J. K.
    Soroceanu, L.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 45 - 45
12345